Dai Hong Bin - Net Worth and Insider Trading
Dai Hong Bin Net Worth
The estimated net worth of Dai Hong Bin is at least $72 Million dollars as of 2024-06-24. Dai Hong Bin is the Directors, senior managers of Jiangsu Hengrui Pharmaceuticals Co Ltd and owns about 1,783,242 shares of Jiangsu Hengrui Pharmaceuticals Co Ltd (SHSE:600276) stock worth over $72 Million. Details can be seen in Dai Hong Bin's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Dai Hong Bin has not made any transactions after 2021-06-11 and currently still holds the listed stock(s).
Transaction Summary of Dai Hong Bin
Dai Hong Bin Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Dai Hong Bin owns 1 companies in total, including Jiangsu Hengrui Pharmaceuticals Co Ltd (SHSE:600276) .
Click here to see the complete history of Dai Hong Bin’s form 4 insider trades.
Insider Ownership Summary of Dai Hong Bin
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SHSE:600276 | Jiangsu Hengrui Pharmaceuticals Co Ltd | 2021-06-11 | Directors & senior managers |
Dai Hong Bin Latest Holdings Summary
Dai Hong Bin currently owns a total of 1 stock. Dai Hong Bin owns 1,783,242 shares of Jiangsu Hengrui Pharmaceuticals Co Ltd (SHSE:600276) as of June 11, 2021, with a value of $72 Million.
Latest Holdings of Dai Hong Bin
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SHSE:600276 | Jiangsu Hengrui Pharmaceuticals Co Ltd | 2021-06-11 | 1,783,242 | 40.41 | 72,060,809 |
Holding Weightings of Dai Hong Bin
Dai Hong Bin Form 4 Trading Tracker
According to the SEC Form 4 filings, Dai Hong Bin has made a total of 7 transactions in Jiangsu Hengrui Pharmaceuticals Co Ltd (SHSE:600276) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Jiangsu Hengrui Pharmaceuticals Co Ltd is the sale of 297,207 shares on June 11, 2021, which brought Dai Hong Bin around $0.
Insider Trading History of Dai Hong Bin
- 1
Dai Hong Bin Trading Performance
GuruFocus tracks the stock performance after each of Dai Hong Bin's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Dai Hong Bin is 6.04%. GuruFocus also compares Dai Hong Bin's trading performance to market benchmark return within the same time period. The performance of stocks bought by Dai Hong Bin within 3 months outperforms 4 times out of 11 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Dai Hong Bin's insider trading performs compared to the benchmark.
Performance of Dai Hong Bin
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 0.8 | | | | | |
| Relative Return to S&P 500(%) | -1.79 | | | | | |
Dai Hong Bin Ownership Network
Dai Hong Bin Owned Company Details
What does Jiangsu Hengrui Pharmaceuticals Co Ltd do?
Who are the key executives at Jiangsu Hengrui Pharmaceuticals Co Ltd?
Dai Hong Bin is the Directors & senior managers of Jiangsu Hengrui Pharmaceuticals Co Ltd. Other key executives at Jiangsu Hengrui Pharmaceuticals Co Ltd include Directors & senior managers Zhang Lian Shan , senior management Sun Xu Gen , and senior management Yuan Kai Hong .
Jiangsu Hengrui Pharmaceuticals Co Ltd (SHSE:600276) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Jiangsu Hengrui Pharmaceuticals Co Ltd (SHSE:600276) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Jiangsu Hengrui Pharmaceuticals Co Ltd (SHSE:600276) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Jiangsu Hengrui Pharmaceuticals Co Ltd (SHSE:600276)'s detailed insider trading history can be found in Insider Trading Tracker table.
Jiangsu Hengrui Pharmaceuticals Co Ltd Insider Transactions
Dai Hong Bin Mailing Address
Above is the net worth, insider trading, and ownership report for Dai Hong Bin. Currently GuruFocus does not have mailing address information for Dai Hong Bin.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
